Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder.

Autor:	Cardamone NC; University of Pennsylvania, Perelman School of Medicine., Stewart RE; University of Pennsylvania, Perelman School of Medicine., Kampman KM; University of Pennsylvania, Perelman School of Medicine., Marcus SC; University of Pennsylvania, School of Social Policy and Practice.
Jazyk:	angličtina
Zdroj:	Research square [Res Sq] 2024 May 03. Date of Electronic Publication: 2024 May 03.
DOI:	10.21203/rs.3.rs-4331201/v1
Abstrakt:	Background: Medications for opioid use disorder (MOUD) are among the best tools we have to combat the opioid epidemic. Yet, use of MOUD among people with opioid use disorder (OUD) remains low. Interventions to increase MOUD access in the United States have largely focused on improving organizational capacity and addressing funding barriers, yet stigma toward MOUD may inhibit uptake even where MOUD is readily available. Substance use disorder (SUD) treatment counselors likely have considerable influence on a client's choice to initiate and adhere to MOUD, but beliefs that counselors convey about MOUD in interaction with clients are understudied. The current study explores what advantages and disadvantages that SUD treatment counselors communicate about buprenorphine, methadone, and naltrexone. Methods: From June to December 2021, we surveyed counselors from publicly-funded SUD treatment agencies under a municipality-wide mandate to offer MOUD to all clients with OUD. Counselors were asked to describe, in a free-response format, the most important advantages and disadvantages to communicate to their clients about taking buprenorphine, methadone, and naltrexone. Counselor responses were coded for one or more advantage and disadvantage. Results: A total of 271 SUD counselors from 29 agencies completed the survey, generating 1,995 advantages and disadvantages across three types of MOUD. The most frequently reported advantage across all three types of MOUD was their ability to reduce cravings and illicit drug use. The most frequently reported disadvantage related to the potential for some types of MOUD to develop long-term medication dependence. Conclusions: As the availability and variety of MOUD treatment options continue to expand, it is important that SUD counselors are equipped with evidence-based recommendations for OUD care. We identified misalignments with the MOUD-prescribing evidence base and stigmatizing language toward MOUD within counselors' responses, highlighting the potential to refine training materials for MOUD and mitigate stigmatizing beliefs. Competing Interests: Declarations Competing interests. The authors declare that there is no conflict of interest.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu